Phase 2 Breast Cancer Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Women between 18 and 75 years old who have been diagnosed with primary (non-spread) breast cancer
- People who are generally able to carry out daily activities with little or no limitation (as measured by a standard health performance scale called ECOG, scoring 0 or 1)
- People whose breast cancer has been confirmed by tissue testing to be invasive, at a stage that has not spread to distant parts of the body (classified as cT1-4/N0-3/M0)
- People whose breast cancer tests strongly positive for a protein called HER2, confirmed through standard laboratory methods
- People whose cancer has been tested to determine whether it responds to hormones (ER and PgR status must be known)
- People who have already received pre-surgery treatment (called neoadjuvant therapy) including at least 9 weeks of a drug called trastuzumab and at least 9 weeks of a type of chemotherapy called a taxane
- People who still have remaining invasive cancer in the breast (larger than 2 cm) or in underarm lymph nodes after pre-surgery treatment, confirmed by a central laboratory
- People who are enrolled within 12 weeks of completing surgery (if no radiation was given after surgery), or within 6 weeks of completing post-surgery radiation therapy
- People whose blood and organ function results fall within the ranges required by the trial, including adequate white blood cell counts, platelet levels, haemoglobin, liver function, kidney function, and heart function (confirm specific values with trial site)
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose breast cancer has spread to other parts of the body (Stage IV or metastatic breast cancer)
- People diagnosed with inflammatory breast cancer
- People who have previously received anti-cancer treatment or radiation therapy for any other cancer, unless it was a fully cured early-stage skin or cervical cancer
- People currently receiving anti-cancer therapy in another clinical trial, including certain bone-strengthening drugs or immunotherapy (confirm details with trial site)
- People who have received any anti-cancer treatment within 28 days before enrolling in the trial
- People experiencing moderate to severe nerve damage in their hands or feet (Grade 2 or higher on a standard medical scale)
- People who have received specific targeted therapy drugs that block HER2 signals, including a drug called pyrrolidone or similar medications
- People who have received high cumulative doses of certain chemotherapy drugs called anthracyclines (specific dose thresholds apply — confirm with trial site)
- People who have had major surgery unrelated to breast cancer before joining the trial, or who have not fully recovered from such surgery
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 13515020716
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
iDFS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.